Letter: Senior Scientists

The Commentary "Senior Scientists Could Play A Key Role In Resolving Big Problems In Peer Review," by David Kritchevsky, and the article "Senior Scientists Face Funding Hurdles, Mandatory Retirement," by Julia King (The Scientist, Jan. 22, 1990, pages 12 and 19), deal with the very important problem of the forced retirement of senior scientists. This waste of human resources first impressed me in 1965. I was then building director of the McIntyre Medical Sciences Building at McGill University.

Written byMurray Saffran
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Commentary "Senior Scientists Could Play A Key Role In Resolving Big Problems In Peer Review," by David Kritchevsky, and the article "Senior Scientists Face Funding Hurdles, Mandatory Retirement," by Julia King (The Scientist, Jan. 22, 1990, pages 12 and 19), deal with the very important problem of the forced retirement of senior scientists.

This waste of human resources first impressed me in 1965. I was then building director of the McIntyre Medical Sciences Building at McGill University. During the planning of the facility, a floor was set aside for the McGill-Montreal General Research Institute, a very active group led by the world-renowned biochemist J.H. Quastel. The institute was the most vigorous biomedical research group at McGill and the most productive center for training graduate students and postdocs. I worked closely with Quastel, his staff, and the building architects to design and build a research facility to their specifications. These ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies